Chenevix-Trench G - Search Results

1

A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.

Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, Giles GG, Southey MC, Chenevix-Trench G, Hopper JL. Spurdle AB, et al. Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):769-74. doi: 10.1158/1055-9965.EPI-06-0776. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17416769 Free article.

2

Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset.

Chenevix-Trench G, Young J, Coggan M, Board P. Chenevix-Trench G, et al. Carcinogenesis. 1995 Jul;16(7):1655-7. doi: 10.1093/carcin/16.7.1655. Carcinogenesis. 1995. PMID: 7614702

3

Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma.

Shanley SM, Chenevix-Trench G, Palmer J, Hayward N. Shanley SM, et al. Carcinogenesis. 1995 Aug;16(8):2003-4. doi: 10.1093/carcin/16.8.2003. Carcinogenesis. 1995. PMID: 7634433

4

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G. Spurdle AB, et al. J Natl Cancer Inst. 1999 Jun 2;91(11):961-6. doi: 10.1093/jnci/91.11.961. J Natl Cancer Inst. 1999. PMID: 10359549

5

CYP17 promotor polymorphism and ovarian cancer risk.

Spurdle AB, Chen X, Abbazadegan M, Martin N, Khoo SK, Hurst T, Ward B, Webb PM, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 May 1;86(3):436-9. doi: 10.1002/(sici)1097-0215(20000501)86:3<436::aid-ijc21>3.0.co;2-a. Int J Cancer. 2000. PMID: 10760835 Free article.

6

Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).

Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, McCredie MR, Giles GG. Hopper JL, et al. J Natl Cancer Inst Monogr. 1999;(26):95-100. doi: 10.1093/oxfordjournals.jncimonographs.a024232. J Natl Cancer Inst Monogr. 1999. PMID: 10854492

7

kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.

Osborne RH, Hopper JL, Kirk JA, Chenevix-Trench G, Thorne HJ, Sambrook JF. Osborne RH, et al. Med J Aust. 2000 May 1;172(9):463-4. doi: 10.5694/j.1326-5377.2000.tb124064.x. Med J Aust. 2000. PMID: 10870547 No abstract available.

8

Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.

Spurdle AB, Webb PM, Chen X, Martin NG, Giles GG, Hopper JL, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 Sep 1;87(5):637-43. Int J Cancer. 2000. PMID: 10925355 Free article.

9

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.

Spurdle AB, Hopper JL, Dite GS, Chen X, Cui J, McCredie MR, Giles GG, Southey MC, Venter DJ, Easton DF, Chenevix-Trench G. Spurdle AB, et al. J Natl Cancer Inst. 2000 Oct 18;92(20):1674-81. doi: 10.1093/jnci/92.20.1674. J Natl Cancer Inst. 2000. PMID: 11036113

10

Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype.

Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G. Spurdle AB, et al. Carcinogenesis. 2001 Jan;22(1):67-72. doi: 10.1093/carcin/22.1.67. Carcinogenesis. 2001. PMID: 11159743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

568 results

Search Page